Gurny, Robert

 
Title Year Hits Downloads
New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance 2015 181 1
Controlled drug release from melt-extrudates through processing parameters: A chemometric approach 2015 189 0
Strategies for formulating and delivering poorly water-soluble drugs 2015 69 1
A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapy 2015 297 2
Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications 2013 217 2
In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application 2013 215 1
In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer 2013 155 0
Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applications 2013 186 3
In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease 2012 215 2
Novel self-associative and multiphasic nanostructured soft carriers based on amphiphilic hyaluronic acid derivatives 2012 3 0
Advantages of bilayered vascular grafts for surgical applicability and tissue regeneration 2012 166 1
Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model 2012 247 1
Novel micelle formulations to increase cutaneous bioavailability of azole antifungals 2011 214 1
Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defect 2011 258 1
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice 2010 206 2
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2) 2010 223 0
The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation 2010 210 0
Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicity 2010 14 0
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size 2009 204 59
Novel thermosensitive chitosan hydrogels: in vivo evaluation 2009 249 2
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation? 2009 195 1
Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems 2009 151 9
Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts 2009 221 0
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells 2009 192 2
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity 2009 3 0
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye 2009 143 12
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer 2009 4 0
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model 2009 187 12
Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis 2009 203 1
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases 2009 205 3
A high throughput protein formulation platform: case study of salmon calcitonin 2009 211 4
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound 2008 183 0
In vivo photodynamic activity of photosensitizer-loaded nanoparticles : formulation properties, administration parameters and biological issues involved in PDT outcome 2008 221 1
Colloidal Drug Delivery Systems - Recent Advances With Polymeric Micelles 2008 360 37
A novel thermoresponsive hydrogel based on chitosan 2008 247 1
Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix 2008 229 5
Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells 2008 12 0
A biodegradable drug delivery system for the treatment of postoperative inflammation 2008 124 1
Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation 2008 142 6
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic acid and 5-aminolevulinic acid derivatives 2008 201 0
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma 2008 206 1
High throughput methods to characterize protein permeation and release 2008 307 1
Nanoparticles for drug delivery : the need for precision in reporting particle size parameters 2008 159 1
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles 2007 137 1
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes 2007 188 0
Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation 2007 198 7
Characterization of protein aggregation: the case of a therapeutic immunoglobulin 2007 220 1
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems 2007 232 2
Polymeric photosensitizer prodrugs for photodynamic therapy 2007 200 1
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus 2007 218 1
High throughput screening of protein formulation stability: practical considerations 2007 190 0
NIR analysis of cellulose and lactose—Application to ecstasy tablet analysis 2007 208 1
Biological conversion of a water-soluble prodrug of cyclosporine A 2007 177 7
Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems 2007 189 1
Detection and characterization of protein aggregates by fluorescence microscopy 2007 202 0
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration 2007 122 0
Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides) 2006 73 1
Biodegradable scleral implants as new triamcinolone acetonide delivery systems 2006 66 1
Biodegradable nanoparticles for direct or two-step tumor immunotargeting 2006 87 0
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer 2006 70 1
Intraocular implants for extended drug delivery: therapeutic applications 2006 109 1
Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH 2006 84 1
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates 2006 29 1
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 2006 96 1
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating 2006 98 0
Ecole de Pharmacie Geneve-Lausanne: A novel center of excellence in Geneva 2005 108 0
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics 2005 77 1
Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the Eye 2005 4 0
Trans-scleral diffusion of triamcinolone acetonide 2005 73 1
A water-soluble prodrug of cyclosporine A for ocular application: A stability study 2005 274 199
Pseudo-thermosetting chitosan hydrogels for biomedical application 2005 64 1
Conversion of cyclosporine A prodrugs in human tears vs rabbits tears 2005 75 0
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos 2004 70 1
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications 2004 65 1
Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance 2004 86 0
New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance 2004 85 3
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting 2004 104 3
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications 2004 40 1
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles 2003 7 0
Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: Screening commercial PLGA and formulation technologies 2003 68 1
In Vitro Monitoring of Poly(ortho ester) Degradation by Electron Paramagnetic Resonance Imaging 2003 242 0
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy 2003 202 0
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles 2002 66 1
Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery 2002 87 0
Ocular tolerance of absorption enhancers in ophthalmic preparations 2002 36 1
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans 2002 122 0
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs 2001 102 0
Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles 2001 74 1
Development of poly(ortho esters) 2001 45 1
Therapeutic applications of viscous and injectable poly(ortho esters) 2001 93 0
Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket 2001 85 1
Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation 2001 73 1
Fluorescence correlation spectroscopy for the characterisation of drug delivery systems 2001 96 0
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle 2001 39 0
Local delivery of antimicrobial agents for the treatment of periodontal diseases 2000 73 1
Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses 2000 76 1
Poly(ortho esters) - A Versatile Drug Delivery System 2000 96 0
Poly(ortho esters) - their development and some recent applications 2000 78 1
Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation 2000 115 1
Formation of peptide impurities in polyester matrices during implant manufacturing 2000 149 1
A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release 2000 178 10
Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants 2000 76 1
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex 1999 87 0
Stability studies of a somatostatin analogue in biodegradable implants 1999 37 1
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization 1999 76 1
Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants 1999 83 3
Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester) 1999 128 0
Ocular tolerance of preservatives on the murine cornea 1999 82 1
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention 1999 79 1
Biodegradable implants 1999 26 4
Production of biodegradable implants for the sustained release of pharmaceuticals 1999 72 1
Protein delivery from extruded poly(ortho esters) 1999 38 4
Synthesis and characterization of self-catalyzed poly(ortho ester) 1998 102 0
Injection-moulding versus extrusion for the preparation of long-acting biodegradable implants 1998 55 1
Topical use of chitosan in ophthalmology : tolerance assessment by confocal microscopy and precorneal retention evaluation by gamma scintigraphy 1998 59 2
Influence of irradiation sterilization on a semi-solid poly(ortho ester) 1998 115 0
pH-Sensitive microparticles as oral delivery systems for antiinfective agents of poor water solubility 1998 77 1
Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections 1998 189 0
A biodegradable polymer designed for concomitant delivery of dexamethasone and 5-fluorouracil to the eye 1998 84 1
Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) containing gentamicin for the treatment of external ophthalmic infections 1998 75 1
Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental caries 1998 82 1
Synthesis and characterization of new bioerodible polymers designed for controlled drug release applications 1998 34 1
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics 1998 46 0
Poly (D,L-lactic acid) nanoparticles as phosphorothioate oligonucleotide carriers in U937 cells 1998 78 1
Chitosan: a unique polysaccharide for drug delivery 1998 101 0
Influence of Irradiation Sterilization on Polymers Used as Drug Carriers : A Review 1997 70 1
Therapeutic applications of retinoids in ophthalmology 1997 36 1
Ocular drug delivery in veterinary medicine 1997 97 0
Synthesis and analysis of viscous poly (ortho-ester) analogs for controlled drug release 1997 77 1
In vivo evaluation of hydrophilic and hydrophobic mucoadhesive semi-solid formulations containing sucralfate and lidocaine for intraoral use 1997 78 1
Determination of dexamethasone in tears by capillary electrophoresis 1997 189 0
Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue 1997 43 0
Formulation and evaluation of zinc-phthalocyanine loaded poly(D,L-lactic acid) nanoparticles 1996 38 13
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systems 1996 102 1
Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels 1995 114 0
Patent Literature Review of Ophthalmic Inserts 1995 92 2
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size 1992 98 1
Long-term histopathological study of new polypeptidic biomaterials 1992 103 2
Aqueous nanodispersions prepared by a salting-out process 1992 84 1
17446 489